The price reduction is being enabled by cutting the list price of its non-branded insulin, Insulin Lispro Injection 100 units/mL, to $25 a vial. List prices for drugs often differ from what ...

Ellison accused Novo Nordisk, Eli Lilly and Sanofi of inflating patients' out-of-pocket costs for insulin based on the wholesale acquisition cost, or list price, of the drug. The drugmakers were ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

Thanks to a federal program that allowed health clinics that serve poor people to buy drugs at steeply discounted prices ... at Erie Health who uses Lantus, an insulin pen. Last fall, after ...

He added his office’s goal is to make sure insulin prices do not increase after these five years. During the press conference, Ellison said diabetic patients were paying about $6,000 a year on ...

Columbus joined a slough of cities, states and counties in suing drug companies and pharmacy benefit managers who they say artificially raised insulin prices for decades and profited from it ...

A prominent point of the online jokes centred around how much money it would have cost Walmart for this, with some netizens estimating “millions.” Walmart had recently given its logo a ...

"We cannot lose one more person to the unconscionably high cost of life that these life saving drugs have been demanded," Ellison said Monday morning. “With this final insulin settlement ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. Insulin prices averaged 19 cents per unit as ...

“Our goal is an absolute price cap [and] lowering that list price of insulin to make sure that it’s affordable and accessible to all,” says Kasper. Together, Kasper says, lowered list prices and ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug manufacturers for allegedly colluding to inflate the cost of insulin.